SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-19-002703
Filing Date
2019-11-12
Accepted
2019-11-12 13:47:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO THE SCHEDULE 13D sc13da412274022_11122019.htm SC 13D/A 429658
2 TERMINATION OF JOINT FILING AND SOLICITATION AGREEMENT, DATED NOVEMBER 12, 2019 ex991to13da412274022_111219.htm EX-99.1 18216
3 JOINT FILING AGREEMENT, DATED NOVEMBER 12, 2019 ex9921to13da412274022_111219.htm EX-99.2 6695
  Complete submission text file 0000921895-19-002703.txt   456085
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Subject) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52343 | Film No.: 191208319
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055B POWERS PLACE SUITE 810 ALPHARETTA GA 30009
Business Address 5348 VEGAS DR., UNIT 733 LAS VEGAS NV 89108 404-664-3629
Altiva Management Inc. (Filed by) CIK: 0001772491 (see all company filings)

IRS No.: 821992901 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A